Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma

Conclusion:The restoration of visual function in glaucoma patients by the RGC replacement therapies requires appropriate protocols and biotechnology methods. Tissue-engineered scaffolds, the generation of retinal organoids, and gene therapy may help to overcome some of the challenges in the generation of clinically safe RGCs.
Source: Tissue Engineering and Regenerative Medicine - Category: Biotechnology Source Type: research